EpiPen Pricing Defended by Shkreli
Martin Shkreli, pharmaceutical patent scavenger, did an interview with CBS and defended Mylan Corp’s inflated pricing of their EpiPen product.
Read moreMartin Shkreli, pharmaceutical patent scavenger, did an interview with CBS and defended Mylan Corp’s inflated pricing of their EpiPen product.
Read more